GDF-15 and Hepcidin Levels in Nonanemic Patients with Impaired Glucose Tolerance
نویسندگان
چکیده
منابع مشابه
GDF-15 and Hepcidin Levels in Nonanemic Patients with Impaired Glucose Tolerance
Aims. Growth Differentiation Factor-15 (GDF-15) has been suggested as one of the regulators of hepcidin, an important regulatory peptide for iron deposition. Current data is conflicting about the relationship between hepcidin and disorders of glucose metabolism. We aimed to investigate serum hepcidin and GDF-15 concentrations and their associations with each other, in nonanemic subjects with im...
متن کاملPrevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in patients with thalassemia major in Iran: A meta-analysis
Background: This study aimed to investigate the prevalence of diabetes, impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) in Iranian patients with thalassemia major. Methods: The current study has been conducted based on PRISMA guideline. To obtain the documents, Persian and English scientific databases such as Magiran, Iranmedex, SID, Medlib, IranDoc, Scopus, PubMed, Scien...
متن کاملEffect of Aerobic and Resistance Training on GDF-15 Levels in Patients with Type 1 Diabetes
Background and purpose: Increasing prevalence of diabetes and its complications, including cardiovascular problems increase the cost of health care which could be diminished with proper planning to change lifestyle. The present study investigated the effect of aerobic and resistance trainings on blood GDF15 level as a protective marker on cardiovascular cells in patients with type 1 diabetes. ...
متن کاملDiabetes mellitus and impaired glucose tolerance in patients with schizophrenia.
OBJECTIVES This study aimed to establish the prevalence of diabetes mellitus (DM) and impaired glucose tolerance in patients with schizophrenia and to elucidate some of the factors associated with hyperglycemia. METHODS We studied a sample of 194 patients with schizophrenia. We determined fasting blood glucose and insulin levels at the start of the testing period; patients were given an oral ...
متن کاملAcarbose improves fibrinolytic activity in patients with impaired glucose tolerance.
Acarbose has been shown to ameliorate insulinemia, suggesting that it may exert favorable effects on the impaired fibrinolytic state in prediabetic patients. We therefore conducted a randomized controlled study to examine the effects of acarbose on fibrinolysis in patients with impaired glucose tolerance (IGT). The participants were randomized to receive (n = 20) or not (control, n = 20) 100 mg...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Diabetes Research
سال: 2016
ISSN: 2314-6745,2314-6753
DOI: 10.1155/2016/1240843